Catalyst Wire Dossier Catalyst Wire Dossier

Solaraze Gel 3% (Diclofenac Sodium)

Diclofenac
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Solaraze Gel 3% (Diclofenac Sodium), covering 2020-07-20 to 2020-07-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis [Phase 3]

See pricing